1. From the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School; Department of Adult Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School; Department of Neurology, Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA.